Systematic investigation of different steroid precursors with respect to their effect on superoxide anion production by human neutrophil granulocytes

Hormone and Metabolic Research

Volumn 36, Issue 3, 2004, Pages 155-163

  Bekesi G ^a   Racz K ^a   Hrabak A ^a   Kakucs, R ^a   Varbiro S ^a   Magyar, Z ^a   Feher J ^a   Dinya, E ^b   Pazmany T ^c   Paku, S ^a   Szekacs B ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b EGIS PHARMACEUTICALS LTD   (Hungary)

^c GEDEON RICHTER LTD   (Hungary)

Author keywords

Antioxidants; Free radicals; Steroid metabolites

Indexed keywords

11ALPHA HYDROXYANDROSTENEDIONE; 11BETA HYDROXYPROGESTERONE; 18 HYDROXYDEOXYCORTICOSTERONE; ANTIOXIDANT; CHOLESTEROL SULFATE; CORTICOSTERONE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FREE RADICAL; HORMONE PRECURSOR; HYPOCHLORITE SODIUM; MYELOPEROXIDASE; STEROID HORMONE; SUPEROXIDE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; NEUTROPHIL; PHOTOMETRY; PRIORITY JOURNAL;

ADULT; AGED; ANTIOXIDANTS; CHOLESTEROL ESTERS; CORTICOSTERONE; DESOXYCORTICOSTERONE; FEMALE; HUMANS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PEROXIDASE; PRODRUGS; STEROIDS; SUPEROXIDES;

EID: 11144356544     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814339     Document Type: Article

References (47)

1. Feher J, Csomos G, Vereckei A. Clinical importance of free radical reactions and their role in the pathogenesis of various human diseases. In: Feher J, Csomos, G, Vereckei, A. (eds). Free radical reactions in medicine. Springer Verlag, 1987
2. Babior BM. Phagocytes and oxidative stress. Am J Med 2000; 109 (1): 33-44
3. Seligman ML, Mitamura J, Shera N, Demopoulos HB. Corticosteroid (methylprednisolone) modulation of photo-peroxidation by ultraviolet light in liposomes. Photochem Photobiol. 1979; 29: 549-558
4. Kellogg EW, Fridovich I. Liposome oxidation and erythrocyte lysis by enzymically generated superoxide and hydrogen peroxide. J Biol Chem 1977; 252 (19): 6721-6728
5. Cathapermal S, Lavigne MC, Leong-Son M, Alibadi T, Ramwell PW. Stereo isomer-specific inhibition of superoxide anion-induced rat aortic smooth muscle cell proliferation by 17 beta-estradiol is estrogen receptor dependent. J Cardiovasc. Pharmacol 1998; 31 (4): 499-505
6. Van Der Vliet A, Smith D, O'Neill CA, Kaur H, Darley-Usmar V, Cross CE, Halliwell B. Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem J 1994; 303: 295-301
7. Ferdinandy P, Panas D, Schulz R. Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts. Am J Physiol 1999; 276: H1861-1867
8. Maziere C, Ronveaus MF, Salmon S, Santus R, Maziere JC. Estrogens inhibit copper and cell-mediated modification of low-density lipoprotein. Atherosclerosis 1991; 89: 175-182
9. Mosca L, Bowlin S, Davidson L, Jenkins P, Pearson TA. Estrogen replacement therapy and lipoprotein (a). Circulation 1991; 84: 546A
10. Arnal JF, Clamens S, Pechet C, Negre-Salvayre A, Allera C, Girolami JP, Salvayre R, Bayard F. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bio-active nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci USA 1996; 93: 4108-4113
11. Buyon JP, Korchak HM, Rutherford LE, Ganguly M, Weissmann G. Female hormones reduce neutrophil responsiveness in vitro. Arthritis Rheum 1984; 27 (6): 623-630
12. Marumo T, Schini-Kerth VB, Brandes RP, Busse R. Gluco-corticoids inhibit superoxide anion production and p22 phox mRNA expression in human aortic smooth muscle cells. Hypertension 1998; 32 (6): 1083-1088
13. Laloraya M, Jain S, Thomas M, Kopergaonkar, Pradeep K, Kumar G. Estrogen surge: a regulatory switch for superoxide radical generation at implantation. Biochem Mol Biol Int 1996; 39 (5): 933-940
14. Roy D, Liehr JG. Temporary decrease in renal quinine reductase activity induced by chronic administration of estradiol to male Syrian hamsters. J Biol Chem 1988; 263 (8): 3646-3651
15. Vol'skii NN, Kozlov VA, Lozovoi VP. Effect of hydrocortisone on superoxide radical production by phagocytosing spleen cells. Biull Eksp Biol Med 1987; 103 (6): 694-696
16. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Prevention of corticosteroid-induced suppression of human polymorph nuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993; 61 (11): 4870-4877
17. de Lamirande E, Harakat A, Gagnon C. Human sperm capacitation induced by biological fluids and progesterone, but not by NADH or NADPH, is associated with the production of superoxide anion. J Androl 1998; 19 (2): 215-225
18. Sugino N, Shimamura K, Tamura H, Ono M, Nakamura Y, Ogino K, Kato H. Progesterone inhibits superoxide radical production by mononuclear phagocytes in pseudo-pregnant rats. Endocrinology 1996; 137 (2): 749-754
19. Kita E, Takahashi S, Yasui K, Kashiba S. Effect of estrogen (17-β estradiol) on the susceptibility of mice to disseminated gonococcus infection. Infect Immun 1985; 49 (1): 238-243
20. Roilides E, Robinson T, Sein T, Pizzo PA, Walsh TJ. In-vitro and ex-vivo effects of cyclosporin A on phagocyte host defences against Aspergillus fumigatus. Anti-microbe Agents Chemother 1994; 38 (12): 2883-2888
21. Szefler SJ, Norton CE, Ball B, Gross JM, Aida Y, Pabst MJ. IFN-gamma and LPS overcome gluco-corticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumour necrosis factor-alpha is not essential for monocyte priming. J Immunol 1989; 142 (11); 3985-3992
22. Békési G, Kakucs R, Várbíró Sz, Rácz K, Sprintz D, Fehér J, Székács B. In-vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytes. Steroids 2000; 65: 889-894
23. Békési G, Kakucs R, Sándor J, Sárváry E, Kocsis I, Sprintz D, Várbíró Sz, Magyar Z, Hrabák A, Fehér J, Székács B. Plasma concentration of myeloperoxidase enzyme in pre-and post-climacterial people: related superoxide anion generation. Exp Gerontol 2001; 37: 137-148
24. Rom WN, Harkin T. Dehydroepiandrosterone inhibits the spontaneous release of superoxide radical by alveolar macrophages in-vitro in asbestosis. Environ Res 1991; 55: 146-156
25. Quarneri C, Melandri G, Caldarera I. Reduced oxidative activity of circulating neutrophils in patients after myocardial infarction. Cell Biochem Funct 1990; 8: 157-162
26. Jansson G. Oestrogen-induced enhancement of myeloperoxidase activity in human polymorph nuclear leukocytes - a possible cause of oxidative stress in inflammatory cells. Free Red Res Commun 1990; 14: 195-208
27. Smith LL. Review of progress in sterol oxidations. Lipids 1996; 31: 453-487
28. Demopoulos HB, Flamm ES, Seligman ML, Pietronigro DD, Tomasula J, DeCrescito V. Further studies on free-radical pathology in the major central nervous system disorders: effect of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury. Can J Physiol Pharmacol 1982; 60: 1415-1424
29. Hall ED, Braughler JM. Acute effects of intravenous gluco-corticoid pre-treatment on the in vitro peroxidation of cat spinal cord tissue. Exp Neurol 1981; 73: 321-324
30. Jacobsen EJ, McCall JM, Ayer DE, VanDoornik FJ, Palmer JR, Belonga KJ, Braughler JM, Hall ED, Houser DJ, Krook MA, Runge TA. Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma. J Med Chem 1990; 33: 1145-1151
31. Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 1987; 262: 10 438-10 440
32. Braughler JM, Burton PS, Chase RL, Pregenzer JF, Jacobsen EJ, VanDoornik FJ, Tustin JM, Ayer DE, Bundy GL. Novel membrane localized iron chelators as inhibitors of iron-dependent lipid peroxidation. Biochem Pharmacol 1988; 37: 3853-3860
33. Braughler JM, Chase RL, Neff GL, Yonkers PA, Day JS, Hall ED, Seth VH, Lathe RA. A new 21-aminosteroid antioxidant lacking gluco-corticoid activity stimulates adrenocorticotropin secretion and blocks arachidonic acid release from mouse pituitary tumour (AtT-20) cells. J Pharm Exp Therap 1988; 244: 423-427
34. Braughler JM, Pregenzer JF. The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxy radicals. Free Rad Biol Med 1989; 7: 125-130
35. Schauer JE, Schelin A, Hanson P, Stratman FW. Dehydroepiandrosterone and a β-agonist, energy transducers, alter antioxidant enzyme systems: influence of chronic training and acute exercise in rats. Arch Biochem Biophys 1990; 283; 503-511
36. Aragno M, Tamagno E, Boccuzzi G, Brignardello E, Chiarpotto E, Pizzini A, Danni O. Dehydroepiandrosterone pre-treatment protects rats against the pro-oxidant and necrogenic effects of carbon tetrachloride. Biochem Pharmacol 1993; 46: 1689-1694
37. Barrou Z, Charru P, Lidy C. Dehydroepiandrosterone (DHEA) and aging. Arch Gerontol Geriat 1997; 24: 233-241
38. Ohtsuka A, Ohtani T, Horiguchi H, Kojima H, Hayashi K. Vitamin E reduces gluco-corticoid-induced growth inhibition and lipid peroxidation in rats. J Nutr Sci Vitamin 1998; 44 (2): 237-247
39. Gürdöl F, Genc S, Öner-Iyidogan Y, Süzme R. Co administration of melatonin and estradiol in rats: Effects on oxidant status. Horm Metb Res 2001; 33: 608-611
40. De Castro CM, Manhaes de Castro R, Fernandes de Medeiros A, Queiros Santos A, Ferreira e Silva WT, Luis de Lima Filho J. Effect of stress on the production of O(2)(-) in alveolar macrophages. J Neuroimmun 2000; 108 (1-2): 68-72
41. Heinle H, Dessouki JB. Luminol-enhanced chemiluminescence after reaction of hydroperoxides with opsonized zymosan. J Biolumin Chemilumin 1995; 10: 71-76
42. Domagk GF, Chilla R. Glucose-6-phosphate dehydrogenase from Candida utilia. Methods Enzymol 1975; 41: 205-208
43. Gionchetti P, Guarnieri C, Campieri M, Belluzzi A, Brignola C, Iannone P, Miglioli M, Barbara L. Scavenger effect of sulfazalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation. Digestive Diseases and Sciences 1991; 36/2: 174-8
44. Guarnieri C, Lugaresi A, Flamigni F, Muscari C, Caldarera C. Effect of oxygen radicals and hyperoxia on rat heart ornithine decarboxylase activity. Biochim Biophys Acta 1982; 718: 157-164
45. Békési G, Kakucs R, Várbíró Sz, Fehér J, Pázmány T, Magyar Z, Sprintz D, Székács B. Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy. British Journal of Obstetrics and Gynaecology 2001; 108: 474-481
46. Heinle H, Brehme U, Friedemann G, Frey JC, Wolf AT, Kelber O, Weiser D, Schmahl FW, Lang F, Schneider W. Intimal plaque development and oxidative stress in cholesterol-induced atherosclerosis in New Zealand rabbits. Acta Physiol Scand 2002; 176: 101-107
47. Hodis HN, Lobo RA, Faxon DP, French WJ, Mehra AO, Shil AB, Selzer RH. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 2003; 349/6: 535-545